JP2009526084A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526084A5
JP2009526084A5 JP2008554516A JP2008554516A JP2009526084A5 JP 2009526084 A5 JP2009526084 A5 JP 2009526084A5 JP 2008554516 A JP2008554516 A JP 2008554516A JP 2008554516 A JP2008554516 A JP 2008554516A JP 2009526084 A5 JP2009526084 A5 JP 2009526084A5
Authority
JP
Japan
Prior art keywords
disease
pharmaceutical composition
composition according
inflammatory
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008554516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526084A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/061909 external-priority patent/WO2008039553A1/en
Publication of JP2009526084A publication Critical patent/JP2009526084A/ja
Publication of JP2009526084A5 publication Critical patent/JP2009526084A5/ja
Pending legal-status Critical Current

Links

JP2008554516A 2006-02-10 2007-02-09 可溶性ＩＬ−１７ＲＣｘ４および炎症における使用法 Pending JP2009526084A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77217706P 2006-02-10 2006-02-10
US78107806P 2006-03-10 2006-03-10
PCT/US2007/061909 WO2008039553A1 (en) 2006-02-10 2007-02-09 Soluble il-17rcx4 and methods of using in inflammation

Publications (2)

Publication Number Publication Date
JP2009526084A JP2009526084A (ja) 2009-07-16
JP2009526084A5 true JP2009526084A5 (enExample) 2010-03-18

Family

ID=38895865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554516A Pending JP2009526084A (ja) 2006-02-10 2007-02-09 可溶性ＩＬ−１７ＲＣｘ４および炎症における使用法

Country Status (10)

Country Link
US (2) US7622116B2 (enExample)
EP (1) EP1987058B1 (enExample)
JP (1) JP2009526084A (enExample)
AT (1) ATE467640T1 (enExample)
AU (1) AU2007300393B2 (enExample)
CA (1) CA2638819A1 (enExample)
DE (1) DE602007006429D1 (enExample)
ES (1) ES2347840T3 (enExample)
IL (1) IL192950A0 (enExample)
WO (1) WO2008039553A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910540B2 (en) * 2004-06-10 2011-03-22 Zymogenetics, Inc. Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation
EA200901154A1 (ru) 2007-03-26 2010-04-30 Займодженетикс, Инк. Растворимые слитые белки il17ra/rc и родственные способы
CA2690568A1 (en) * 2007-06-20 2008-12-24 Schering Corporation Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
GB2464183A (en) * 2008-09-19 2010-04-14 Singulex Inc Sandwich assay
WO2010096394A2 (en) 2009-02-17 2010-08-26 Redwood Biosciences, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
MX2011009362A (es) 2009-03-05 2011-09-26 Abbott Lab Proteinas de union a il-17.
WO2010144358A1 (en) 2009-06-08 2010-12-16 Singulex, Inc. Highly sensitive biomarker panels
JP2011032170A (ja) * 2009-07-29 2011-02-17 Morinaga Milk Ind Co Ltd ヒト細胞ｉｌ−１７産生抑制剤
WO2011096438A1 (ja) * 2010-02-03 2011-08-11 国立大学法人 東京大学 腸疾患の治療方法及び治療用医薬組成物
JP2013525820A (ja) 2010-05-06 2013-06-20 シングレクス、インコーポレイテッド 関節リウマチの発症に関するリスクを診断し、病期分類し、予測し、治療レスポンダーを同定するための方法
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
CA2824143C (en) 2011-01-14 2018-12-18 Redwood Bioscience, Inc. Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
US9284283B2 (en) 2012-02-02 2016-03-15 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating IL-17
SG11201802887PA (en) 2015-10-27 2018-05-30 Ucb Biopharma Sprl Methods of treatment using anti-il-17a/f antibodies
EP3448885A4 (en) 2016-04-26 2020-01-08 R.P. Scherer Technologies, LLC ANTIBODY CONJUGATES AND METHOD FOR THE PRODUCTION AND USE THEREOF
CN111218425B (zh) * 2019-01-17 2022-02-08 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.
CN112250764B (zh) * 2020-10-22 2022-07-29 深圳市康瑞克生物科技有限责任公司 一种抗白细胞介素17a的单克隆抗体、其编码基因及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684032A (en) * 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
ATE279517T1 (de) 1995-03-23 2004-10-15 Immunex Corp Il-17 receptor
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US20020177188A1 (en) * 1998-05-15 2002-11-28 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6569645B2 (en) * 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6579520B2 (en) * 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
WO2001046420A2 (en) 1999-12-23 2001-06-28 Genentech, Inc. Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
AU7276098A (en) 1997-05-01 1998-11-24 Zymogenetics Inc. Mammalian cytokine-like receptor
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
WO1999014240A1 (en) 1997-09-17 1999-03-25 Human Genome Sciences, Inc. Interleukin-17 receptor-like protein
CA2332109A1 (en) 1998-05-12 1999-11-18 Human Genome Sciences, Inc. 97 human secreted proteins
AU6069800A (en) 1999-07-07 2001-01-30 Zymogenetics Inc. Human cytokine receptor
US20030199041A1 (en) * 1999-07-07 2003-10-23 Presnell Scott R. Interleukin-17 receptor homologue
WO2001090357A1 (en) 2000-05-24 2001-11-29 Genesis Research & Development Corporation Limited Compositions isolated from skin cells and methods for their use
CN1444652A (zh) * 2000-05-24 2003-09-24 先灵公司 哺乳动物受体蛋白;相关试剂和方法
US6793919B2 (en) * 2000-10-18 2004-09-21 Immunex Corporation Methods for treating rheumatoid arthritis using IL-17 antagonists
WO2002038764A2 (en) 2000-11-10 2002-05-16 The Regents Of The University Of California Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
US20040097447A1 (en) * 2002-11-16 2004-05-20 Isis Pharmaceuticals Inc. Modulation of interleukin 22 receptor expression
US7910540B2 (en) * 2004-06-10 2011-03-22 Zymogenetics, Inc. Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation
KR20070107703A (ko) * 2005-02-14 2007-11-07 와이어쓰 인터루킨-１７ｆ 항체 및 기타 ｉｌ-１７ｆ 신호전달안타고니스트 및 그의 용도
US20070249533A1 (en) * 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same
PT1931697E (pt) * 2005-09-28 2010-12-06 Zymogenetics Inc Antagonistas de il-17a e il-17f e processos para a sua utilização

Similar Documents

Publication Publication Date Title
JP2009526084A5 (enExample)
JP2008509227A5 (enExample)
JP2009534297A5 (enExample)
JP2009510093A5 (enExample)
JP2020193195A5 (enExample)
JP2010511056A5 (enExample)
EA035973B9 (en) Amino acid sequences directed against il-17a, il-17f and/or il-17a/f and polypeptides comprising the same
US9920098B2 (en) Protein ligand for affinity isolation matrix
FI3592384T3 (fi) Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään
RU2009124453A (ru) Гетеродимерные полипептиды il-17 a/f и возможности их лечебного применения
CN114957472B (zh) 抗IL-4Rα的单域抗体以及应用和药物
JP2017510575A5 (enExample)
CN104098694B (zh) 抗人β2微球蛋白的单域抗体及其制备方法和用途
HRP20140150T1 (hr) Antitijela koja vežu il-4 i/ili il-13 i njihova uporaba
JP2010500005A5 (enExample)
JP2008508885A5 (enExample)
RU2017118325A (ru) Слитые серпиновые полипептиды и способы их применения
RU2017145308A (ru) Слитые серпиновые полипептиды и способы их применения
JP2012519489A5 (enExample)
CN103403020A (zh) 蛋白a的新型耐碱变体及其在亲和色谱中的用途
JP2014530611A5 (enExample)
JP2015511637A5 (enExample)
HRP20191334T1 (hr) Anti-fcrn antitijela
JP2010075175A (ja) 改善された特異性を有する新規免疫グロブリン結合タンパク質
JP2015524790A5 (enExample)